EYE vs RXST: stock comparison and AI forecast
National Vision Holdings, Inc. (EYE) and Rxsight, Inc. (RXST) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EYE National Vision Holdings, Inc.
- Price
- $17.90 -17.9% · 6M
- Market Cap
- $1.42B
- P/E Ratio
- 43.7x
- Size
- small-cap
- AI Forecast
RXST Rxsight, Inc.
- Market Cap
- $189M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- EYE is 7.5 times larger than RXST by market capitalization ($1.42B against $189M).
- EYE carries 1.21 times debt per unit of equity, against 0.34 times for RXST.
- Both companies share the SEC industry classification Ophthalmic Goods.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EYE | RXST |
|---|---|---|
| Market Cap | $1.42B | $189M |
| P/E Ratio | 43.66x | – |
| P/B Ratio | 1.58x | 0.74x |
| EPS | $0.41 | $-1.10 |
| Book Value/Share | $11.34 | $6.13 |
| Revenue/Share | $25.72 | $2.93 |
| FCF/Share | $0.62 | $0.45 |
Profitability & Margins
| Metric | EYE | RXST |
|---|---|---|
| ROE | – | -20.9% |
| ROA | – | -15.7% |
| ROIC | 5.2% | -23.1% |
| Gross Margin | 58.6% | 76.1% |
| Operating Margin | 4.1% | -50.4% |
| Net Margin | – | -43.8% |
| EBT Margin | 3.4% | -43.7% |
| Tax Rate | 26.3% | -0.2% |
Financial Health
| Metric | EYE | RXST |
|---|---|---|
| Current Ratio | 0.59x | 4.20x |
| Quick Ratio | 0.27x | 3.67x |
| D/E Ratio | 1.21x | 0.34x |
| Financial Leverage | 2.21x | 1.34x |
| Interest Coverage | 5.9x | -6172.7x |
| Working Capital | -$156M | $240M |
Cash Flow
| Metric | EYE | RXST |
|---|---|---|
| Operating Cash Flow | $130M | $24M |
| Free Cash Flow | $49M | $19M |
| Capital Spending | -$81M | -$5M |
| OCF Growth YoY | -10.4% | – |
| FCF Growth YoY | -13.5% | – |
| FCF/Sales | 2.4% | 15.3% |
| CapEx/Sales | 4.0% | 4.1% |
Operational Efficiency
| Metric | EYE | RXST |
|---|---|---|
| Asset Turnover | 1.03x | 0.36x |
| Receivables Turnover | 58.3x | 7.2x |
| Inventory Turnover | 6.9x | 0.7x |
| Fixed Assets Turnover | 6.0x | 8.3x |
| Days Sales Outstanding | 6 days | 51 days |
| Days Inventory | 53 days | 497 days |
| Payables Period | 33 days | 43 days |
| Cash Conversion Cycle | 26 days | 505 days |
Income Statement
| Metric | EYE | RXST |
|---|---|---|
| Total Revenue | $2.03B | $122M |
| Operating Income | $83M | -$61M |
| Net Income | – | -$53M |
| R&D Expense | – | $37M |
| SG&A Expense | $1.01B | $117M |
| Cost of Goods Sold | $841M | $29M |
Dividend & Shareholder Information
| Metric | EYE | RXST |
|---|---|---|
| Shares Outstanding | 79M | 42M |
EYE vs RXST: stock comparison and AI forecast
Which is bigger, EYE or RXST?
EYE is 7.5 times larger than RXST by market capitalization ($1.42B against $189M).
Which one does Intratio's AI model rank higher, EYE or RXST?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.